×

Novel use of 2h-benzimidazol-2-one, 1,3-Dihydro-1-(2{4-[3-(trifluoromethyl)phenyl]-1-piperazinyl}ethyl)-and its physiologically acceptable addition salts

  • US 20040180904A1
  • Filed: 05/04/2004
  • Published: 09/16/2004
  • Est. Priority Date: 05/11/2001
  • Status: Active Grant
First Claim
Patent Images

1. Use of 2H-benzimidazol-2-one, 1,3-dihydro-1-(2-{4-[3-(trifluoromethyl)phenyl]-1-piperazinyl}ethyl)- or a physiologically acceptable acid addition salt thereof, for the manufacture of a medicament for the treatment of extrapyramidal movement disorders.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×